IVUS vs OCT to Guide PCI: Which Should We Choose?

Controlling stent expansion with optical coherence tomography (OCT) based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the control group which used intravascular ultrasound (IVUS) and superior the angiography only group. Based on these study outcomes and the prior outcomes, we should use IVUS imaging if available. 

IVUS vs OCT para guiar la angioplastia ¿Cuál elegir?

There are no specific algorithms to guided PCI with OCT and neither is there much information on its relative benefits vs. IVUS.

The iSIGHT trial carried out by our Brazilian colleagues, recently published in Circulation Cardiovascular Interventions, has provided significant data on the matter, which makes us proud. 

All patients receiving PCI in at least one native lesion in coronary arteries between 2.25 and 4 mm in diameter, were randomized 1:1:1 to OCT, IVUS or angiography alone. 

An external elastic membrane–based protocol was applied for stent sizing in patients guided by IVUS and OCT.

The primary end point was non-inferiority of OCT vs IVUS to reach optimal stent expansion (minimum stent area ≥90% of the average reference lumen area)


Read also: Cerebral Protection Devices during TAVR in the Daily Practice.


It included 156 lesions (151 patients), 51 receiving OCT, 52 IVUS and 53 angiography.

Stent expansion with OCT (98.01 ± 16.14%) resulted non-inferior to the one obtained with IVUS (91.69 ± 15.75%) and superior to the angiography one (90.53 ± 14.84%, p=0.041).

Stent expansion obtained with IVUS was not superior to the one obtained with angiography alone (p=0.921). This should not discourage the use of IVUS, supported by significant evidence. 

Conclusion

Stent expansion with OCT based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the one obtained with IVUS and superior to the one obtained with angiography.

Original Title: Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions. The iSIGHT Randomized Trial.

Reference: Daniel Chamié et al. Circulation: Cardiovascular Interventions. 2021;14:e009452. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009452.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Coronary perforations during PCI are one of the most dreaded complications in interventional cardiology, especially in bifurcations. Though rate, this critical situation requires an...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...